4.4 Article

Swine IFI6 confers antiviral effects against Japanese encephalitis virus in vitro and in vivo

Journal

JOURNAL OF GENERAL VIROLOGY
Volume 104, Issue 4, Pages -

Publisher

MICROBIOLOGY SOC
DOI: 10.1099/jgv.0.001847

Keywords

IFI6; Japanese encephalitis virus; Bip; host antiviral factor

Ask authors/readers for more resources

Swine are important intermediate hosts in the cycle of Japanese encephalitis virus (JEV) infection. This study identified swine interferon alpha-inducible protein 6 (sIFI6) as a host factor that possesses antiviral activity against JEV. The results showed that overexpression of sIFI6 inhibited JEV infection, while sIFI6 knockdown enhanced JEV infection in PK-15 cells. The study also found that the antiviral activity of sIFI6 was regulated by endoplasmic reticulum (ER) stress-related protein, Bip.
Swine are considered to be an important intermediate host in the cycle of Japanese encephalitis virus (JEV) infection. Most existing antiviral studies of JEV mainly focus on the host factor of the dead- end hosts. However, little research has addressed this in swine. Here, we found that swine interferon alpha- inducible protein 6 (sIFI6) possessed antiviral activity against JEV. In vitro studies showed that overexpression of sIFI6 inhibited the infection of JEV, while sIFI6 knockdown enhanced the infection of JEV in PK- 15 cells. In addition, we also found that the structural integrity of sIFI6 was required by anti- JEV activity and that sIFI6 interacted with JEV nonstructural protein 4A (NS4A), an integral membrane protein with a pivotal function in replication complex during JEV replication. The interaction domain was mapped to the fourth transmembrane domain (TMD), also known as the 2K peptide of NS4A. The antiviral activity of sIFI6 was regulated by endoplasmic reticulum (ER) stress- related protein, Bip. In vivo studies revealed that sIFI6 alleviated symptoms of JEV infection in C57BL/6 mice. In addition, the antiviral spectrum of sIFI6 showed that sIFI6 specifically inhibited JEV infection. In conclusion, this study identified sIFI6 as a host factor against JEV infection for the first time. Our findings provide a potential drug target against JEV infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available